Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

NCT00066248

Conditions: Astrocytoma, Blast Crisis, Body Weight, +83 more
Locations: CCOP - Bay Area Tumor Institute Oakland, California, United States

Children's Hospital & Research Center Oakland Oakland, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Florida Shands Cancer Center Gainesville, Florida, United States

View all 43 locations

View Trial Details

Completed

Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer

NCT01660360

Conditions: Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Study of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid Tumors

NCT01170897

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations: Ramesh K. Ramanathan M.D. Scottsdale, Arizona, United States

Mayo Clinic - Scottsdale Scottsdale, Arizona, United States

cCare - California Cancer Associatesfor Research Excellence Encinitas, California, United States

Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer

NCT00091832

Conditions: Bone Metastases in Subjects With Advanced Breast Cancer, Breast Cancer, Breast Diseases, +10 more
Locations: Not specified

View Trial Details

Completed

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

NCT00502736

Conditions: Bone Diseases, Bone Neoplasms, Musculoskeletal Diseases, +10 more
Locations: Ankara, Turkey (Türkiye)

Ankara, Turkey (Türkiye)

Istanbul, Turkey (Türkiye)

Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Rapamycin Plus Bevacizumab in Advanced Cancers

NCT00667485

Conditions: Advanced Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Rapamycin With Grapefruit Juice for Advanced Malignancies

NCT00375245

Conditions: Adenoma, Adnexal Diseases, Breast Diseases, +73 more
Locations: University of Chicago Hospitals Chicago, Illinois, United States

View Trial Details

Completed

Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer

NCT01045304

Conditions: Breast Cancer, Metastatic, Breast Diseases, Breast Neoplasms, +8 more
Locations: Sanofi-Aventis Investigational Site Number 036002 Parkville, Australia

Sanofi-Aventis Investigational Site Number 036001 Perth, Australia

Sanofi-Aventis Investigational Site Number 036003 Westmead, Australia

Sanofi-Aventis Investigational Site Number 056001 Brussels, Belgium

View all 20 locations

View Trial Details

Completed

Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy

NCT00083616

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +14 more
Locations: Not specified

View Trial Details

Completed

Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence

NCT02032368

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: Department of Interventional Radiology; Cancer Center; Guangdong General Hospital Guangzhou, Guangdong, China

View Trial Details

Neoplastic Processes

Neoplastic Processes trial results

Related conditions